CredibleMeds Recently Cited in Two Recent Scientific Papers Published by the AHA and JACC
We’re excited to announce that CredibleMeds was recently cited in two papers published by both the American Heart Association (AHA), and the Journal of the American College of Cardiology (JACC). These recent studies made use of CredibleMeds’ trusted, online database of QT-prolonging medicines and its imbedded risk categories to support their findings.
In the first paper, the JACC published the 2017 guidelines for the prevention of sudden death in patients with ventricular arrhythmias. The set of practice guidelines have been continually updated by the American College of Cardiology (ACC) and the AHA since 1980, are supported by years of scientific evidence, with the primary objective of recommending the best clinical methods to improve cardiovascular health and prevent sudden death. JACC cited CredibleMeds’ list of commonly used QT-Prolonging medicines as a reference in their recommendations for Long QT Syndrome.
The second paper, published by the AHA, was an update to practice standards for electrocardiographic monitoring in hospital settings. Endorsed by the ACC, the American Association of Critical-Care Nurses (AACN), and the Pediatric and Congenital Electrophysiology Society (PACES), the new scientific statement provides a comprehensive review of evidence-based recommendations for indications, duration, and implementation of continuous electrocardiographic monitoring of hospitalized patients. This most recent version provided a significant update to the current collection of scientific standards that were last published in 2004. The CredibleMeds list of drugs that are associated with a known risk for Torsade de Pointes (TdP) was cited in the paper’s overview on QTc monitoring in patients with TpP.
The citation of CredibleMeds’ online QTdrugs list in both the AHA and JCC’s recent scientific papers highlights the increasing utility that CredibleMeds and its critically important resources provide, not just to patients and providers, but also to the healthcare and research community at large. We hope that our collection of online resources continues to support important studies around the world as part of our continuing mission to promote safe medicination use for patients and their families.